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background:  Proinflammatory dendritic cells (DCs) and monocytes are critically involved in the proceeding and destabilization of atherosclerosis. 
Recent studies have reported potential associations of specific patterns of circulating DCs and monocytes with the incidence of coronary artery 
disease (CAD) and ST-elevation myocardial infarction (STEMI); however, further information of DC and monocyte subsets on plaque morphology and 
vulnerability is uncertain and required.
methods: Thirty-eight CAD patients with borderline lesions (stenosis 50%-70%) by coronary angiography (CAG) were enrolled, while 27 subjects 
free of luminal diameter narrowing ≥ 50% served as controls. Likewise, 32 patients with STEMI were enrolled and confirmed with the presence 
of thrombosis by CAG. Plaque features of 38 CAD patients were evaluated at the site of the minimum lumen area and culprit lesions by optical 
coherence tomography. Peripheral blood (6 ml) was collected from each patient and drawn into heparin-anticoagulated tubes at entry. Circulating 
myeloid DCs (mDCs), plasmacytoid DCs (pDCs) and monocyte subsets were analyzed using flow cytometry.
results: There was no discrepancy in the peripheral total white blood cell count, differential count among three groups. Compared to control 
group, patients with CAD and STEMI had significantly lower proportions of mDC1, mDC2, pDC and a remarkable higher proportion of monocytes with 
intermediate CD16 expression (Mon2, CD14+CD16+) in peripheral blood. In the OCT subgroup, patients with thin-cap fibroatheroma (TCFA) had a 
lower proportion of mDC2 than those without TCFA (0.72% ± 0.41% and 1.39% ± 0.38%, P=0.025). Otherwise, Mon2 proportion retained a higher 
level in patients with TCFA relative to those without TCFA (17.69% ± 3.32% and 13.01% ± 2.71%, P=0.031). When proportions were converted into 
absolute value, as oppose to a gradual rise in the number of Mon2/ml, the number of mDC2/ml remain gradually decreased with the progress of 
plaque vulnerability.
Conclusion: Circulating subsets of mDC2 and Mon2 appear to be promosing markers of plaque stabilization and rupture.
